Roche Holding sells 4 billion Swiss francs of bonds
Roche Holding AG, Switzerland's biggest drugmaker by sales, sold 4 billion Swiss francs of bonds due in 3 and 8 years, taking its total bond offerings to $34 billion in the past 2 weeks.
Roche is making a $230 million bet on hepatitis C drug developer Anadys Pharmaceuticals, a company the big Swiss drug maker agreed to buy for a whopper of a premium.